Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG
Clinical trial NCT03304054 · COMPLETED
Trial details
- NCT number
- NCT03304054
- Sponsor
- Catalyst Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-18
- Primary completion
- 2020-01-31
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.